| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 128.682 | 79 |
| GSM780708 | Untreated after 4 days (C2_1) | 178.468 | 82 |
| GSM780709 | Untreated after 4 days (C3_1) | 199.824 | 84 |
| GSM780719 | Untreated after 4 days (C1_2) | 147.515 | 80 |
| GSM780720 | Untreated after 4 days (C2_2) | 198.175 | 83 |
| GSM780721 | Untreated after 4 days (C3_2) | 240.646 | 85 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 196.923 | 83 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 161.21 | 81 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 212.913 | 84 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 223.532 | 85 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 164.308 | 81 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 218.389 | 84 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 151.985 | 81 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 192.134 | 83 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 187.352 | 83 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 162.978 | 81 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 204.832 | 84 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 155.476 | 81 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 209.312 | 84 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 206.271 | 84 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 184.033 | 83 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 208.851 | 84 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 195.723 | 83 |